- $6.82m
- $5.14m
- $29.21m
Brief: Xwell Registers Resale Of Up To 138.7 Million Shares Of Common Stock From Time To Time By Selling Stockholders - SEC Filing
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:09 AM
NASDAQ RESUMED AT 09:57 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:49 AM
Brief: Xwell Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules
Wellness services firm XWELL's Q3 operating loss narrows
Brief: XWELL Enters Securities Exchange And Amendment Agreement With Series G Preferred Stock Holders - SEC Filing
Brief: XWELL Q2 Net Income USD -2.3 Million
Brief: XWELL Launches All-New Website, Offering Seamless Booking And Unified Access To Health, Wellness & Beauty Services
Brief: XWELL Q1 Net Income USD -4.7 Million
Brief: XWELL plans to buy select medical spas by the end of 2025
Brief: XWELL Says Center For Disease Control And Prevention Has Extended Its Traveler-Based Genomic Surveillance Program
Brief: XWELL Appoints Ezra Ernst As New President And Chief Executive Officer
Brief: XWELL Comments on CPC’s Withdrawal of Proxy Fight, Related Lawsuit
Brief: XWELL Announces Director Candidate Nomination Notice Submitted By CPC Is Invalid
Brief: CPC Pain & Wellness Spv, Llc Reports Stake Of 9.42% In Xwell, Inc As Of June 10, 2024 - SEC Filing
Brief: Xwell To Determine Effect Of Misapplication Of GAAP As Related To Impairment Of Treat Business Segment
Brief: Xwell's US GAAP Misapplication Related To Impairment Of Treat Inc Business Segment Ended Sept 30, 2023